Search Results - "Kohlhaw, K"
-
1
Photodynamic therapy for advanced bile duct cancer: Evidence for improved palliation and extended survival
Published in Hepatology (Baltimore, Md.) (01-02-2000)“…Median survival time of nonresectable hilar bile duct cancer is only 4 to 6 months owing to tumor spread in the biliary tree, refractory cholestasis, and…”
Get full text
Journal Article -
2
Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results
Published in Transplantation proceedings (01-11-2001)Get full text
Journal Article -
3
Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/tacrolimus
Published in Experimental and clinical endocrinology & diabetes (2000)“…The induction of diabetes has been recognised as adverse effect of the immunsuppressive drug FK506/Tacrolimus. The aim of this study was to clarify whether…”
Get more information
Journal Article -
4
Low-dose sirolimus and tacrolimus in kidney transplantation: first results of a single-center experience
Published in Transplantation proceedings (01-11-2001)Get full text
Journal Article -
5
The monoclonal anti-CD4 antibody RIB5/2 induces donor-specific tolerance in the high-responder liver transplant model in the rat
Published in Transplantation proceedings (01-05-2001)Get full text
Journal Article Conference Proceeding -
6
Living related kidney transplantation between identical twins
Published in Transplantation proceedings (01-09-2002)Get full text
Journal Article Conference Proceeding -
7
Does simultaneous pancreas kidney transplantation still lead to a higher morbidity than kidney transplantation alone?
Published in Transplantation proceedings (01-09-2002)Get full text
Journal Article Conference Proceeding -
8
Anti-CD4-induced long-term acceptance of rat liver allografts in a high-responder model is not based on pure immunosuppression
Published in Transplantation proceedings (01-05-2001)Get full text
Journal Article -
9
Cyclosporine monitoring in liver allograft recipients: two distinct patterns of blood level derangement associated with nephrotoxicity
Published in Transplantation proceedings (01-06-1990)“…The parallel measurement of specific and nonspecific CyA levels by second generation radioimmunoassays based on monoclonal antibodies proved to be an effective…”
Get more information
Journal Article -
10
Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II study
Published in Gastrointestinal endoscopy (01-07-2004)“…Median survival of patients with non-resectable hilar cholangiocarcinoma is 3 to 6 months, even after biliary drainage. Therefore, a single-arm phase II study…”
Get full text
Journal Article -
11
Apoptosis and the expression of Fas and Fas-ligand antigen after orthotopic liver transplantation
Published in Transplantation proceedings (01-08-1998)Get full text
Journal Article Conference Proceeding -
12
Serum bile acids and esterified bilirubin in early detection and differential diagnosis of hepatic dysfunction following orthotopic liver transplantation
Published in Journal of hepatology (01-02-1993)“…Routine laboratory tests are of little help for early detection and differential diagnosis of hepatic dysfunction following orthotopic liver transplantation…”
Get more information
Journal Article -
13
Ciclosporin metabolite pattern in blood and urine of liver graft recipients. I. Association of ciclosporin metabolites with nephrotoxicity
Published in European journal of clinical pharmacology (01-10-1991)“…Blood ciclosporin (Cs) metabolite pattern in 58 liver grafted patients was routinely monitored by HPLC from the first Cs dose after transplantation until…”
Get full text
Journal Article -
14
Organ transplantation: what are the limits?
Published in Transplantation proceedings (01-12-1992)Get more information
Journal Article -
15
Investigations on the metabolic pathways of cyclosporine: II. Elucidation of the metabolic pathways in vitro by human liver microsomes
Published in Xenobiotica (1991)“…1. Cyclosporine and its metabolites, isolated from human bile and identified by FAB mass spectrometry and 1H-n.m.r. spectroscopy, were metabolized by human…”
Get more information
Journal Article -
16
Evaluation of hepatic excretory system function by determination of serum bile acid clearance early after liver transplantation
Published in Transplantation proceedings (01-12-1992)Get more information
Journal Article -
17
Association of very high blood levels of cyclosporin metabolites with clinical complications after liver transplantation
Published in Transplantation proceedings (01-02-1989)Get more information
Journal Article -
18
Cure of hepatic-based inborn errors of metabolism by liver transplantation
Published in Transplantation proceedings (01-12-1992)Get more information
Journal Article -
19
Biologic activity of cyclosporine metabolites
Published in Transplantation proceedings (01-06-1990)Get more information
Journal Article -
20
Cyclosporine and bilirubin metabolites compete for the hepatic excretory system
Published in Transplantation proceedings (01-10-1994)Get more information
Journal Article